Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments.

52W Range

40thpctl

Volume

0.56×avg

Market Cap

2.27BUSD

P/E Ratio

-7.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Ocular Therapeutix, Inc.

OCULNASDAQ Global Market·USD·Closed

Ocular Therapeutix, Inc.

OCULNASDAQ·USD·Closed

$10.36

−4.25%

$10.36

−$0.46 (4.25%)

52W Range

40thpctl

Volume

0.56×avg

Mkt Cap

2.27BUSD

P/E

-7.3TTM

Div Yield

–ann

OCUL: Ocular Therapeutix, Inc. Stock Analysis | finqOS